{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T07:05:10Z","timestamp":1770275110524,"version":"3.49.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1987,7,1]],"date-time":"1987-07-01T00:00:00Z","timestamp":552096000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[1987,7]]},"DOI":"10.1007\/bf00915552","type":"journal-article","created":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T03:36:31Z","timestamp":1104550591000},"page":"304-311","source":"Crossref","is-referenced-by-count":39,"title":["Patients with condyloma acuminatum exhibit decreased interleukin-2 and interferon gamma production and depressed natural killer activity"],"prefix":"10.1007","volume":"7","author":[{"given":"Roberto","family":"Cauda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen K.","family":"Tyring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo E.","family":"Grossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arabella B.","family":"Tilden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth D.","family":"Hatch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"W. Mitchell","family":"Sams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Baron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J.","family":"Whitley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF00915552_CR1","first-page":"11","volume":"99","author":"H Pfister","year":"1984","unstructured":"Pfister H: Biology and biochemistry of papillomaviruses. Rev Physiol Biochem Pharmacol 99:11\u2013181, 1984","journal-title":"Rev Physiol Biochem Pharmacol"},{"key":"BF00915552_CR2","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/ajcp\/61.5.702","volume":"61","author":"J Kovi","year":"1974","unstructured":"Kovi J, Tillman RL, Lee SM: Malignant transformation of condyloma acuminata. Am J Clin Pathol 61:702\u2013710, 1974","journal-title":"Am J Clin Pathol"},{"key":"BF00915552_CR3","first-page":"794","volume":"36","author":"H ZurHausen","year":"1976","unstructured":"ZurHausen H: Condyloma acuminata and human genital cancer. Cancer Res 36:794, 1976","journal-title":"Cancer Res"},{"key":"BF00915552_CR4","first-page":"489","volume":"50","author":"G Trinchieri","year":"1984","unstructured":"Trinchieri G, Perussia B: Human natural killer cells: Biologic and pathogenic aspects. Lab Invest 50:489\u2013513, 1984","journal-title":"Lab Invest"},{"key":"BF00915552_CR5","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1084\/jem.160.4.1147","volume":"160","author":"G Trinchieri","year":"1984","unstructured":"Trinchieri G, Matsumoto-Kobayashi M, Clark S, Seehra J, London L, Perussia B: Response of resting human peripheral blood natural killer cells to interleukin 2. J Exp Med 160:1147\u20131169, 1984","journal-title":"J Exp Med"},{"key":"BF00915552_CR6","first-page":"81","volume":"22","author":"RS Blumberg","year":"1985","unstructured":"Blumberg RS, Schooley RT: Lymphocyte markers and infectious diseases. Semin Hematol 22:81\u2013114, 1985","journal-title":"Semin Hematol"},{"issue":"Suppl","key":"BF00915552_CR7","first-page":"31","volume":"21","author":"A Hoyum","year":"1968","unstructured":"Hoyum A: Isolation of leukocytes from human blood. Methyl cellulose, dextran, and ficoll as erythrocyte-aggre-goting agents. Scand J Clin Lab Invest (Suppl) 21:31\u201350, 1968","journal-title":"Scand J Clin Lab Invest"},{"key":"BF00915552_CR8","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1182\/blood.V65.1.149.149","volume":"65","author":"A Velardi","year":"1985","unstructured":"Velardi A, Prchal JT, Prasthofer EF, Grossi CE: Expression of NK-lineage markers on peripheral blood lymphocytes with T-helper (Leu 3+\/T 4+) phenotype in B cell chronic lymphocytic leukemia. Blood 65:149\u2013155, 1985","journal-title":"Blood"},{"key":"BF00915552_CR9","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.4049\/jimmunol.127.3.1024","volume":"127","author":"T Abo","year":"1981","unstructured":"Abo T, Balch CM: A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1). J Immunol 127:1024\u20131029, 1981","journal-title":"J Immunol"},{"key":"BF00915552_CR10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF00915477","volume":"1","author":"HF Pross","year":"1981","unstructured":"Pross HF, Baines MG, Rubin P, Shragge P, Patterson MS: Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity. J Clin Immunol 1:51\u201366, 1981","journal-title":"J Clin Immunol"},{"key":"BF00915552_CR11","first-page":"233","volume":"1","author":"M Wiranowska-Stewart","year":"1981","unstructured":"Wiranowska-Stewart M, Stewart WE II: Determination of human leukocyte populations involved in production of interferons alpha and gamma. J IFN Res 1:233\u2013234, 1981","journal-title":"J IFN Res"},{"key":"BF00915552_CR12","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1128\/IAI.22.1.62-68.1978","volume":"22","author":"MP Langford","year":"1978","unstructured":"Langford MP, Stanton GJ, Johnson HM: Biological effects of staphylococcal entertoxin A on human peripheral lymphocytes. Infect Immun 22:62\u201368, 1978","journal-title":"Infect Immun"},{"key":"BF00915552_CR13","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.4049\/jimmunol.120.6.2027","volume":"120","author":"S Gillis","year":"1978","unstructured":"Gillis S, Ferm M, Ou W, Smith KA: T cell growth factor: Parameters of production and quantitative microassay for activity. J Immunol 120:2027\u20132032, 1978","journal-title":"J Immunol"},{"key":"BF00915552_CR14","first-page":"1249","volume":"21","author":"JB Campbell","year":"1975","unstructured":"Campbell JB, Grunberger T, Kochman MA, White SL: A microplaque reduction assay for human and mouse interferon. Can J Microbiol 21:1249\u20131253, 1975","journal-title":"Can J Microbiol"},{"key":"BF00915552_CR15","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0140-6736(81)91390-8","volume":"2","author":"FA Ennis","year":"1981","unstructured":"Ennis FA, Beare AS, Riley D, Schild GC, Meager A, Qui YH, Schwarz G, Rook AH: Interferon induction and increased natural killer cell activity in influenza infections in man. Lancet 2:891\u2013893, 1981","journal-title":"Lancet"},{"key":"BF00915552_CR16","doi-asserted-by":"crossref","first-page":"282","DOI":"10.4049\/jimmunol.118.1.282","volume":"118","author":"LM Perrin","year":"1977","unstructured":"Perrin LM, Tishon A, Oldstone MBA: Immunological injury in measles virus infection. III. Presence and characterization of human cytotoxic lymphocytes. J Immunol 118:282\u2013290, 1977","journal-title":"J Immunol"},{"key":"BF00915552_CR17","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.4049\/jimmunol.126.5.2036","volume":"126","author":"GV Quinnan Jr","year":"1981","unstructured":"Quinnan GV Jr, Kirmani N, Esber E, Saral R, Manischewitz FF, Rogers JL, Rook AH, Santos GW, Burns WH: HLA-restricted cytotoxic T lymphocyte and nonthymic cytotoxic lymphocyte responses to cytomegalovirus infection of bone marrow transplant recipients. J Immunol 126:2036\u20132041, 1981","journal-title":"J Immunol"},{"key":"BF00915552_CR18","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/00007890-198402000-00009","volume":"37","author":"SE Starr","year":"1984","unstructured":"Starr SE, Smiley L, Wlodaverc C, Friedman HM, Plotkin SA, Barker C: Natural killing of cytomegalovirus infected targets in renal transplant recipients. Transplantation 37:161\u2013164, 1984","journal-title":"Transplantation"},{"key":"BF00915552_CR19","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1172\/JCI110981","volume":"72","author":"AH Rook","year":"1983","unstructured":"Rook AH, Masur H, Lane HC, Frederick W, Kasahara T, Macher AM, Djeu JY, Manischewitz JF, Jackson L, Fauci AS, Quinnan GV Jr: Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome. J Clin Invest 72:398\u2013403, 1983","journal-title":"J Clin Invest"},{"key":"BF00915552_CR20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1056\/NEJM198207013070102","volume":"307","author":"GV Quinnan","year":"1982","unstructured":"Quinnan GV, Kirmani N, Rock AH, Manischewitz J, Jackson L, Moreschi G, Santos GW, Saral R, Burns WH: Cytotoxic T cells in cytomegalovirus infection: HLA-restricted T lymphocyte and non T lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone marrow-transplant recipients. N Engl J Med 307:7\u201313, 1982","journal-title":"N Engl J Med"},{"key":"BF00915552_CR21","first-page":"1445","volume-title":"NK Cells and Other Natural Effector Cells","author":"C Lopez","year":"1981","unstructured":"Lopez C, Kirkpatrick D, Fitzgerald P: The role of NK (HSV-1) effector cells in the resistance to herpes virus infections in man.In NK Cells and Other Natural Effector Cells, RB Herberman (ed). New York, Academic Press, 1981, pp 1445\u20131450"},{"key":"BF00915552_CR22","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.4049\/jimmunol.131.4.1789","volume":"131","author":"LL Lanier","year":"1983","unstructured":"Lanier LL, Le AM, Phillips JH, Warner NL, Babcock GF: Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens. J Immunol 131:1789\u20131796, 1983","journal-title":"J Immunol"},{"key":"BF00915552_CR23","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.4049\/jimmunol.131.6.2757","volume":"131","author":"A Landay","year":"1983","unstructured":"Landay A, Gartland GL, Clement LT: Characterization of a phenotypically distinct subpopulation of Leu 2+ cells which suppresses T cell proliferative responses. J Immunol 131:2757\u20132761, 1983","journal-title":"J Immunol"},{"key":"BF00915552_CR24","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/BF00917143","volume":"4","author":"LT Clement","year":"1984","unstructured":"Clement LT, Dagg MK, Landay A: Characterization of human lymphocyte subpopulations: Alloreactive cytotoxic T-lymphocyte precursor and effector cells are phenotypically distinct from Leu 2+ suppressor cells. J Clin Immunol 4:395\u2013402, 1984","journal-title":"J Clin Immunol"},{"key":"BF00915552_CR25","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.4049\/jimmunol.130.3.1171","volume":"130","author":"AB Tilden","year":"1983","unstructured":"Tilden AB, Abo T, Balch CM: Suppressor cell function of human granular lymphocytes identified by the HNK-1 (Leu 7) monoclonal antibody. J Immunol 130:1171\u20131175, 1983","journal-title":"J Immunol"},{"key":"BF00915552_CR26","first-page":"1135","volume":"42","author":"SP James","year":"1983","unstructured":"James SP, Neckers LM, Graef S, Cossman J, Balch CM, Strober W: Suppression of immunoglobulin synthesis by lymphocytes reactive with Leu 2a and HNK-1 in patients with Crohn's disease. Fed Proc 42:1135, 1983 (abstr)","journal-title":"Fed Proc"},{"key":"BF00915552_CR27","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.4049\/jimmunol.129.4.1752","volume":"129","author":"T Abo","year":"1982","unstructured":"Abo T, Cooper MD, Balch CM: Characterization of HNK-1 (Leu 7) human lymphocytes. I. Two distinct phenotypes of human NK cells with different cytotoxic capacities. J Immunol 129:1752\u20131757, 1982","journal-title":"J Immunol"},{"key":"BF00915552_CR28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1128\/IAI.40.1.35-38.1983","volume":"40","author":"DA Weigent","year":"1983","unstructured":"Weigent DA, Langford MP, Fleischmann WR Jr, Stanton GJ: Potentiation of lymphocyte natural killing by mixtures of alpha or beta interferon with recombinant gamma interferon. Infect Immun 40:35\u201338, 1983","journal-title":"Infect Immun"},{"key":"BF00915552_CR29","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1056\/NEJM198512123132403","volume":"313","author":"HW Murray","year":"1985","unstructured":"Murray HW, Hillman JK, Rubin BY, Kelly CD, Jacobs JL, Tyler LW, Donelly DM, Carriero SM, Godbold JH, Roberts RB: Patients at risk for AIDS-related opportunistic infections: Clinical manifestations and impaired gamma interferon production. N Engl J Med 313:1504\u20131510, 1985","journal-title":"N Engl J Med"},{"key":"BF00915552_CR30","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1172\/JCI112194","volume":"76","author":"HM Murray","year":"1985","unstructured":"Murray HM, Welte K, Jacobs JL, Rubin BY, Mertelsmann R, Roberts RB: Production of and in vitro response to interleukin-2 in the acquired immunodeficiency syndrome. J Clin Invest 76:1959\u20131964, 1985","journal-title":"J Clin Invest"},{"key":"BF00915552_CR31","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1001\/archderm.1986.01660150050014","volume":"122","author":"JC Vance","year":"1986","unstructured":"Vance JC, Bart BJ, Hansen RC, Reichman RC, McEwen C, Hatch KD, Berman B, Tanner DJ: Intralesional recombinant alpha-2 interferon for the treatment of patients with condyloma acuminatum or verruca plantaris. Arch Dermatol 122:272\u2013277, 1986","journal-title":"Arch Dermatol"},{"key":"BF00915552_CR32","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/infdis\/152.2.249","volume":"152","author":"SH Chandler","year":"1985","unstructured":"Chandler SH, Alexander ER, Holmes KK: Epidemiology of cytomegaloviral infection in a heterogeneous population of pregnant women. J Infect Dis 152:249\u2013256, 1985","journal-title":"J Infect Dis"},{"key":"BF00915552_CR33","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.4049\/jimmunol.130.6.2737","volume":"130","author":"T Miyawaki","year":"1983","unstructured":"Miyawaki T, Yachie A, Ohzeki S, Nagaoki T, Taniguchi N: Cyclosporin A does not prevent expression of TAC antigen, a probable TCGF receptor molecule, on mitogen-stimulated human T cells. J Immunol 130:2737\u20132742, 1983","journal-title":"J Immunol"},{"key":"BF00915552_CR34","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.4049\/jimmunol.131.5.2379","volume":"131","author":"T Kasahara","year":"1983","unstructured":"Kasahara T, Djeu JY, Dougherty SF, Oppenheim JS: Capacity of human large granular lymphocytes (LGL) to produce multiple lymphokines: Interleukin 2, interferon and colony stimulating factor. J Immunol 131:2379\u20132385, 1983","journal-title":"J Immunol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00915552.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00915552\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00915552","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00915552.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T07:55:37Z","timestamp":1682927737000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00915552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1987,7]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1987,7]]}},"alternative-id":["BF00915552"],"URL":"https:\/\/doi.org\/10.1007\/bf00915552","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[1987,7]]}}}